Inactive Instrument
Pandion Therapeutics, Inc. Stock
Stocks
PAND
US6983401067
Biotechnology & Medical Research
| 1 day | +0.22% |
| Manager | Title | Age | Since |
|---|---|---|---|
Gregg Beloff
DFI | Director of Finance/CFO | 58 | - |
| Chief Tech/Sci/R&D Officer | - | 01/08/2020 | |
Edward Freedman
COO | Chief Operating Officer | 57 | - |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 01/04/21 | Tender | Chief Technology Officer | 335,035 | 1.1351% | ||
| 01/04/21 | Tender | Director | 14,997 | 0.0508% | ||
| 01/04/21 | GSK Equity Investments Ltd.
| Tender | Company | 5,688,218 | 19.2719% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +0.22% | +0.13% | - | - | 1.7B | |
| -0.08% | +0.34% | +57.44% | +108.50% | 54.92B | |
| -0.34% | +3.51% | +45.55% | +40.16% | 44.31B | |
| +0.29% | +6.20% | -14.80% | -19.65% | 22.96B | |
| -0.40% | +3.49% | -1.29% | +387.06% | 21.12B | |
| -3.36% | -0.13% | +12.83% | -36.99% | 16.31B | |
| -1.44% | -2.73% | +6.24% | -41.48% | 15.19B | |
| -0.24% | +2.44% | +27.43% | +177.49% | 13.32B | |
| +1.96% | +10.27% | +19.80% | - | 12.48B | |
| +0.32% | +2.81% | +96.37% | +213.49% | 11.21B | |
| Average | -0.31% | +2.75% | +27.73% | +103.57% | 23.54B | |
| Weighted average by Cap. | -0.34% | +2.86% | +32.12% | +95.25% |
Employees
56
